位置:首页 > 产品库 > 重组磷酸化间变性淋巴瘤激酶核相互作用伴侣蛋白
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
重组磷酸化间变性淋巴瘤激酶核相互作用伴侣蛋白
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。

重组间变性淋巴瘤激酶核相互作用伴侣蛋白
Recombinant ZC3HC1
基因名:

ZC3HC1


产品别名:

HSPC216; NIPA; ZC3HC1; zinc finger C3HC-type containing 1; zinc finger C3HC-type containing 1; zinc finger C3HC-type protein 1; nuclear-interacting partner of ALK; hematopoietic stem/progenitor cell protein 216; nuclear interacting partner of anaplastic lymphoma kinase (ALK); 磷酸化间变性淋巴瘤激酶核相互作用伴侣蛋白; 间变性淋巴瘤激酶核相互作用伴侣蛋白;


背景信息:
The regulated oscillation of protein expression is an essential mechanism of cell cycle control. The SCF class of E3 ubiquitin ligases is involved in this process by targeting cell cycle regulatory proteins for degradation by the proteasome, with the F-box subunit of the SCF specifically recruiting a given substrate to the SCF core. NIPA (nuclear interaction partner of ALK) is a human F-box-containing protein that defines an SCF-type E3 ligase (SCFNIPA) controlling mitotic entry. Assembly of this SCF complex is regulated by cell-cycle-dependent phosphorylation of NIPA, which restricts substrate ubiquitination activity to interphase. Nuclear cyclin B1 is a substrate of SCFNIPA. Inactivation of NIPA by RNAi results in nuclear accumulation of cyclin B1 in interphase, activation of cyclin B1-Cdk1 kinase activity, and premature mitotic entry. Thus, SCFNIPA-based ubiquitination may regulate S-phase completion and mitotic entry in the mammalian cell cycle.
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025